Preparation of Azide Biosynthetic Surrogates of myo-inositol
Leave this area blank for abstract info. 1 Typically through initial phosphorylation events, inositol derivatives (e.g., inositol triphosphates, IP 3 , and lipidated phosphatidylinositols, PIs) play key roles in modulating calcium signaling, membrane functioning, cell death, cell division and cell-to-cell communication. 2, 3 Additional glycosylation and lipidation events eventually yield higher order glycolipids, such as the glycosylphosphatidylinositols (GPIs) and polymannosylated lipids, including the phosphatidyl-myo-inositol mannosides (PIMs) and lipoarabinomannans (LAMs). These glycolipids are essential components in anchoring functional proteins on extracellular membrane surfaces and intracellular trafficking processes, and are key to host-cell recognition, immunological processes, and pathogenic infections. 4 In this study, we have a view to prepare biosynthetic mimics of myo-inositol (azide-surrogates) that have the potential to be metabolically incorporated into a chosen cell type (e.g., yeast). For this purpose, the modification or introduction of bioorthogonal functional groups ("click" functionalities) was necessary. Herein, we chose to introduce azide groups to replace the different hydroxyl groups of myo-inositol (1) (Figure 1 ). For symmetry reasons, this would result in four regioisomeric series of myo-cyclohexanols 2-5, of which two (the 2-series and 5-series) would be meso (achiral). A few routes to the synthesis of optically active azido and amino inositols have been reported. Examples of routes start from p-benzoquinone 5 or conduritol-E 6 via chemo-enzymatic resolution, and also from chiral sources such as L-quebrachitol. 7 Among various synthetic protocols developed for the synthesis of myo-inositol intermediates and its analogues, commercially available myo-inositol 1 is the most commonly preferred starting material due to its low cost and pre-defined relative stereochemistry.
8 For myo-inositol, positions C 1 , C 3 and C 4 , C 6 are equivalent and unsymmetrical protection leads to racemates. The chemical synthesis of optically active inositol analogues would thus necessitate the resolution of racemic inositol intermediates (chemically, enzymatically or via desymmetrization techniques) 9 or by starting with an alternative chiral material (e.g., via the Ferrier carbo-cyclization of sugars).
10
For our biological studies, the racemic azido-inositol series 3 and 4, and the meso series 2 and 5, were considered sufficient to test our hypothesis of metabolic selection and incorporation into live cells. Our synthetic routes to make 2-5 are described herein.
As a prelude to biomolecular incorporation studies, practical routes to a series of four regioisomeric azido-deoxy derivatives of inositol that mimic the natural myo-stereochemistry are described. Starting from commercially available myo-inositol, the regioselective and stereoselective introduction of azide functionality was achieved at the C-2, C-3, C-4 and C-5 positions via azide displacement of the corresponding O-sulfonates of suitably protected scyllo-, chiro-, epi-and neo-inositols, respectively. Notably, a final one-pot acetolysis method conveniently allowed for rapid access to pentaacetate azido-deoxy inositols. Investigations on the metabolic incorporation of these myo-inositol azide surrogates in both acetate and free alcohol forms are in progress.
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Synthesis of (±)-4-Deoxy-4-Azido myo-Inositols 4:
We first decided to pursue the dicyclohexylidene diketal protection approach reported by Angyal and co-workers 11 as a starting material over diacetals or diisopropylidene derivatives. 12, 13 This allows for the practical, differential hydroxyl protection of myo-inositol (1) as relatively stable trans and cis cyclohexylidenes that not only tolerate multi-step synthesis, but also result in reactivity differences between the two remaining hydroxyl groups. The 1,2,4,5-dicyclohexylidene myo-inositol 6 was isolated as a white solid in 22% yield after recrystallisation from 1:9 acetone/petroleum ether.
14 The remaining two isomeric ketals (2,3,4,5-and 3,4,5,6-dicyclohexylidenes) can be converted to 6 in a sequence of partial deprotection-reprotection steps. ii. BaO, Ba(OH)2·8H2O, BnBr, DMF, 60%; iii. DMP, DCM, rt, 93%; iv. NaBH4, EtOH, 0 °C, 76%; v. Tf2O, Py, DCM 0 °C to rt, 73%; vi. 11, AcOH, Ac2O, 10% H2SO4 in Ac2O, rt; vii. NaOMe, MeOH, rt, 99%.
Barium oxide and barium hydroxide chelation-mediated benzylation of 6 produced the monobenzylated myo-inositol derivative 7 as the major product in 60% yield 14 (Scheme 1). The free alcohol at the C 6 position of the myo-inositol derivative 7 was subsequently oxidised under Dess-Martin periodinane (DMP) conditions to give the desired ketone 8 in excellent yield (93%). Stereoselective reduction of 8 by sodium borohydride produced the epi-alcohol 9 15 exclusively. The free C 6 alcohol of epi-inositol 9 was subsequently activated as its triflate 10 using trifluoromethane sulfonic acid anhydride in pyridine. 16 In accordance with the report of Schlewer et al., 15 azide displacement of triflate 10 gave the desired myo-product 11 together with trace amounts of the enol ether side-product 12 via 1,2-anti elimination under the basic conditions. After several methods were explored, global deprotection of 11 in the presence of the azide group was eventually achieved in one step by acetolysis 17 using a mixture of sulphuric acid, acetic anhydride and acetic acid to afford the 4-deoxy-4-azido-myoinositol pentaacetate 4a 5, 6 in 65% yield. Minor amounts of the partially acetolysed product 3-benzyl-6-azido-myo-inositol tetraacetate 13 was also obtained, which could be transformed under the same conditions to yield 4a. Further methanolysis in the presence of a catalytic amount of sodium methoxide afforded the 4-deoxy-4-azido-myo-inositol analogue 4b. Single crystals of pentacetate 4a, from 1:1 hexane/ethyl acetate, confirmed the stereochemistry unambiguously by X-ray analysis (Figure 2 ). 
Synthesis of meso-5-Deoxy-5-Azido myo-Inositols 5:
Starting with the dicyclohexylidene diol 6, benzylation of the two remaining hydroxyl groups afforded the fully protected inositol derivative 14 in excellent yield 18 (Scheme 2). The kinetically labile and slightly distorted trans ketal of the compound 14 was cleaved selectively by controlled acid hydrolysis using acetyl chloride in DCM/MeOH (3:1) to afford the diol 15 in 68% yield. 19 The diol 15 was regioselectively benzylated under phase transfer catalyst (tetrabutyl ammonium hydrogen sulphate) conditions, resulting in a separable mixture of benzylated products 16 and 17. 20 Due to difficulties to distinguish 16 from 17, both alcohols were converted to their corresponding methylated derivatives 18a,b for identification purposes. Subsequent removal of the cis-ketal unit and global benzylation of 18a,b provided the fully protected inositol derivatives 20a and 20b, respectively. The 1 H and 13 C NMR of the derived mesocompound (20b) clearly indicated the structure to be 5-O-methyl-1,2,3,4,6-penta-O-benzyl myo-inositol. Thus, the corresponding starting alcohol 17 was confirmed to possess the C 5 -free alcohol for the synthesis of the desired 5-series azido-analogues 5. DMP, NaHCO3, DCM, rt, 85%; viii. NaBH4, EtOH, rt, 60%; ix. Tf2O, Py, 0 °C, 71%; x. NaN3, DMF, rt, 83%; xi. Ac2O, AcOH, 10% H2SO4 in Ac2O, 60 °C, 64%; xii. NaOMe, MeOH, rt, 98%.
Having identified the C 5 -OH derivative, the C 5 -stereochemistry of 17 was inverted by DMP oxidation followed by reduction of the ketone 21 to give the alcohol 22 in the neoconfiguration (Scheme 2). In the reduction step, the original alcohol 17 was also formed in 36 % yield, presumably due to similar sterics being encountered by the hydride reagent when approaching from either the α or β face in 21. The alcohol 22 was then converted into its trifluoromethane sulfonate 23 by treatment with Tf 2 O in pyridine. Next, the azide group was installed by a clean substitution in an S N 2 fashion with sodium azide to regenerate the myo-configured product 24 in good yield. Interestingly, no elimination (enol) product was detected, presumably due to 1,3-diaxial sterics preventing E 2 -elimination. Compound 24 was then subjected to exhaustive acetolysis to form the 5-deoxy-5-azido-myo-inositol pentaacetate 5a. 17 In this case, an elevated temperature 60 °C was required for complete conversion to the pentaacetate 5a. 6 The isomeric, partially acetolysed, benzyl ether products were also converted to 5a under the same acetolysis conditions. Deacetylation of 5a was accomplished by methanolysis in the presence of catalytic amounts of sodium methoxide to yield 5-deoxy-5-azido-myoinositol 5b. Single crystals of compound 5a from 1:1 hexane/ether confirmed the structure unambiguously by X-ray analysis (Figure 3) . 
Synthesis of (±)-3-Deoxy-3-Azido myo-Inositols 3:
Inspired by the report of Watanabe et al. 16b for an efficient S N 2 substitution of C 3 -inositol triflates, the synthesis of the 3-series 3a,b was studied by consecutive double substitution at the C 3 position of an inositol intermediate 26, which was obtained from the previously synthesized inositol derivative 7 by subsequent methoxy methyl (MOM) ether protection to form the fully protected 25 and Pd-C hydrogenolysis (Scheme 3). 21 The C 3 -free alcohol 26 was treated with trifluoromethane sulfonic acid anhydride in pyridine to yield the corresponding triflate 27, which was immediately reacted with potassium acetate in DMA to furnish the C 3 -inverted chiro-acetate 28 in excellent yield (96%) 16b without elimination, presumably due to the less basic nature of the acyl anion as compared to azide species.
Deacetylation of chiro-28 in the presence of catalytic amounts of sodium methoxide gave the axial alcohol 29 (Scheme 3). After completion, acidic resin was added to the reaction mixture to remove sodium ions by ion exchange. Unexpectedly, the trans ketal unit of 29 rearranged into a more stable cis C3/C4-ketal (30) by ketal migration under the slightly acidic conditions. Hence, a basic aqueous work up procedure using ethylacetatewater was employed while scaling up. The free axial alcohol in 29 was subsequently treated with triflic anhydride and pyridine to form the triflate 31. Excess pyridine led to formation of an eliminated product (35) in minor amounts. Two equivalents of pyridine in dichloromethane, however, generated the trifluoromethane sulfonylated product 31 in 90% yield without elimination. On the other hand, the free axial alcohol of 29 could be smoothly mesylated in pyridine as the solvent to form 32 without elimination, presumably due to the lower leaving group aptitude of OMs as compared to OTf. 22 The isolated triflate 31 was examined first. Treatment with sodium azide in DMF generated the myo-configured substitution product 33 in low yield (15%) together with a minor S N 1 substitution product 34 (10%) and the elimination product 35 in 56% yield. 23 In comparison, the mesylate derivative 32 failed to undergo azide displacement with sodium azide in DMF, even upon heating at 70 °C. Also, Mitsunobu reaction of the alcohol 29 in order to achieve direct azide displacement was unsuccessful. We thus opted to optimise the azide displacement of triflate 31 by screening differing azide reagents and solvents: NaN 3 /DMA, NaN 3 /Me 2 CO/H 2 O, n Bu 4 NN 3 /DCM, TMSN 3 /TBAF/THF. Eventually, the combination of excess TMSN 3 (8 equiv.) in the presence of (0.5 equiv.) of TBAF in THF medium provided myoazide 33 in a 43% optimal yield. 24 To complete the 3-series, global acetolysis of compound 33 formed the desired 3-deoxy-3-azido myo-inositol pentaacetate 3a 5 in moderate yield (Scheme 3) under mildly acidic conditions (2% H 2 SO 4 in acetic anhydride). Treatment of 33 in dry, ethereal HCl further allowed all acid labile protecting groups to be cleaved in one step and 3-deoxy-3-azido-myo-inositol 3b could be isolated cleanly as a white solid after an ether wash.
Synthesis of meso-2-Deoxy-2-Azido myo-Inositols 2:
Following the orthoformate protection approach of Kishi et al. 25 , which allows for large differences in reactivity between equatorial and axial hydroxyl groups of inositol in terms of sterics and electronics, 26 a route to the 2-series of azide analogues was developed (Scheme 4). The symmetric dibenzyl myo-inositol orthoformate 37 27 was prepared from the dibenzoate derivative 36 through a prolonged silver(I) oxide chelation mediated bisbenzylation 28 and aminolysis sequence. The equatorial free hydroxyl group of 37 was oxidised under DMP condition to give the ketone 38 in excellent yield. Next, stereoselective reduction of ketone 38 produced the inverted axial alcohol 39 in the scylloconfiguration exclusively. 25 The rigidity of the orthoformate unit presumably accounts for this highly stereoselective reduction step. The axially positioned free alcohol of 39 was then sulfonylated 22 by treatment with methane sulfonyl chloride in pyridine to give 40 in excellent yield. At this stage, an S N 2 attack at C 2 of compound 40 was presumed to be sterically challenging. Hence, orthoformate cleavage of compound 40 was performed first, and the triol 41 was formed by mild methanolysis with pTSA. 29 Next, the mesylate derivative 41 was heated with sodium azide in DMF, which formed the myo-configured azide substituted product 42 in moderate yield, along with minor amounts of the epoxide 43 and some unreacted starting material 41. No elimination product was identified in this case; however, the reaction required heating at 80 °C, which led to decomposition of some material. Final exhaustive acetolysis of 42 completed the synthesis of the desired 2-deoxy-2-azido-myoinositol pentaacetate 2a in good yield. Clean methanolysis under Tetrahedron 4 basic conditions regenerated the free hydroxyl groups to produce meso 2-deoxy-2-azido-myo-inositol 2b. 
Summary
In this letter, we have described straighforward routes to various azido-deoxy inositol analogues through azide installation. As a common strategy, we adopted a consecutive S N 2 doubleinversion approach on suitably protected inositol derivatives, which were derived via convenient oxidation-reduction sequences from myo-inositol. A final, global acetolysis step in the presence of the azide group (2-15% sulphuric acid in acetic anhydride/acid) enabled the direct and convenient synthesis of azido-inositol pentaacetate analogues 2a-5a. Methanolysis by treatment with catalytic sodium methoxide subsequently provided the fully unprotected azido myo-inositol surrogates 2b-5b cleanly. The routes are convenient and provide sufficient material for biological study. Having genuine azide-surrogates of myo-inositol in hand, a more concise and diversified strategy is under investigation. In the meantime, the metabolic incorporation of these modified azido inositol analogues into various inositol lipids of yeast cells are in progress, and lipid profiling and biosynthetic cell compatabilities will be reported in due course.
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• Practical routes to all azido-deoxy derivatives of myo-inositol are described.
• Regio-and stereo-controlled introduction of azide functionality were achieved.
• Key scyllo-, chiro-, epi-and neo-inositols were prepared as intermediates.
• A final, one-pot acetolysis gave convenient access to the pentaacetate forms.
• Metabolic, biosynthetic incorporation of these azide surrogates are in progress.
